File this under ‘Say Uncle.’ A dozen drug and device makers have told Chuck Grassley, the Iowa Republican, that they have plans or are working on plans to publicly disclose grants to outside groups, and the details will be provided on each company’s Web sites, the Associated Press reports. In particular, Grassley is interested in [...]

He’s an elected official in Washington DC, who regularly skewers this or that drugmaker with letters seeking all kinds of info. His hearings can be eventful. And his press releases don’t mince words. Who is he? If you guessed Chuck Grassley, Bart Stupak or Henry Waxman you could be forgiven. But in a piece by [...]

Let’s take one problem at a time. First, there are fresh concerns over potentially troubling safety data from a late-stage study of the biotech’s drug for postmenopausal osteoporosis, known as denosumab. Wall Street is worried because results show the med increased bone density in both early and late stage postmenopausal women, but patients had a [...]

Chuck Grassley, the Republican senator from Iowa, will propose a bill requiring drugmakers to disclose payments to docs for consulting, lectures and seminar attendance, The New York Times reports. Grassley is one of several lawmakers to propose a federal registry. Minnesota, Vermont and Maine have similar registries; other states are considering them.
In a speech on [...]

Yet another FDA medical reviewer allegedly was harassed from the Avandia review for raising red flags, according to a letter written yesterday by US Senators Chuck Grassley and Max Baucus to FDA commish Andy von Eschenbach. Here’s a key portion…
“During a recent interview with Finance Committee staff, a senior medical officer in the Office of [...]

Chuck is reacting to a spate of news reports last week that mostly centered on Amgen, which is already under a microscope for its marketing practices to doctors and its failure to report clinical trial data properly. Now, Grassley sent letters to the FDA, the drugmaker and the Centers for Medicare & Medicaid Services seeking [...]

In a letter e-mailed today to Lilly ceo Sid Taurel, US Sen. Chuck Grassley, who sits on the Senate Finance Committee, asks for “all documents and materials, including, but not limited to, emails, letters, reports, and memoranda, that were made available to the court-appointed” lawyers on the plaintiffs’ steering committees in the Zyprexa product-liability litigation.
Grassley [...]

“Every excuse under the sun has been used to create roadblocks, even in the face of Congressional subpoenas requesting information and access to FDA employees,” he told the House Energy and Commerce Committee’s oversight committee this morning, where he appeared as a witness in a hearing about prescription-drug safety.
“In denying access to documents responsive to [...]

That’s what sources are saying, even though no formal announcement has been made. Nonetheless, Room 2123 in the Rayburn House Office Building has been reserved that morning by the House Energy and Commerce Committee, which has jurisdiction over the FDA. And U.S. Sen. Chuck Grassley, an outspoken FDA critic, is scheduled to appear as a [...]